Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 30, 2019 16:05 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies to Present at the 38th Annual J.P. Morgan Healthcare Conference

SEATTLE, Dec. 30, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), today announced the company will be participating in the upcoming 38th...
December 09, 2019 08:00 ET | Source: Adaptive Biotechnologies

Adaptive and AbbVie Partner Across Multiple Myeloma Trials to Measure Minimal Residual Disease Using the clonoSEQ® Assay

SEATTLE, Dec. 09, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:ADPT) today announced a multi-year, global collaboration agreement with AbbVie (NYSE: ABBV) to utilize...
December 04, 2019 16:30 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies and Collaborators to Present Data from More Than 25 clonoSEQ® Abstracts at ASH 2019 Demonstrating Clinical Relevance of Standardized, Accurate MRD Testing for Blood Cancer Patients

Research and real-world evidence support the use across a range of leukemias and lymphomas and demonstrate utility in multiple tissue types, including blood and bone marrow Late breaker presentation...
November 12, 2019 16:05 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Corporation Reports Third Quarter 2019 Financial Results

SEATTLE, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT) today reported financial results for the quarter ended September 30, 2019....
October 29, 2019 16:05 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies to Report Third Quarter Financial Results on November 12, 2019

SEATTLE, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies (Nasdaq: ADPT) today announced that it will report financial results for the third quarter of 2019 after market close on Tuesday,...
September 24, 2019 08:00 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Enters Partnership with Illumina to Develop Distributable IVD Test Kits for clonoSEQ and immunoSEQ Dx

SEATTLE, Wash., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...
September 17, 2019 08:00 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Enters Partnership for Use Of clonoSEQ® as Preferred MRD Test for Drug Development Across Amgen’s Hematology Franchise

SEATTLE, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:ADPT) today announced it has entered into a global agreement with Amgen for the use of Adaptive’s...
August 13, 2019 16:05 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Corporation Reports Second Quarter 2019 Financial Results

SEATTLE, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT) today reported financial results for the quarter ended June 30, 2019. “At...
August 07, 2019 08:30 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Executes Lease for New 100,000 Square Foot Corporate Headquarters, Tripling its Footprint in Seattle’s Growing Biotech Hub

SEATTLE, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:ADPT), a commercial-stage biotechnology company that reads and translates the genetic code of the adaptive...
August 01, 2019 16:15 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies to Report Second Quarter Financial Results on August 13, 2019

SEATTLE, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies (Nasdaq: ADPT) today announced that it will report financial results for the second quarter of 2019 after market close on Tuesday,...